ICD-10 Code M31.4: Aortic arch syndrome [Takayasu]

Key Takeaways

ICD-10 Code M31.4 is the billable diagnosis code for aortic arch syndrome [Takayasu], effective October 1, 2025 for the 2026 ICD-10-CM edition.

The code captures Takayasu arteritis, a rare large-vessel granulomatous vasculitis affecting the aorta and its main branches, also called pulseless disease.

Accurate use of ICD-10 Code M31.4 requires documented specialist confirmation, vessel involvement, and disease activity in the medical record.

Pabau’s claims management software helps rheumatology and vascular practices attach the correct ICD-10 diagnosis codes to procedures and reduce claim errors.

ICD-10 Code M31.4 is the billable diagnosis code for aortic arch syndrome [Takayasu], the ICD-10-CM label for Takayasu arteritis. It covers confirmed cases of this large-vessel granulomatous vasculitis affecting the aorta and its main branches, effective October 1, 2025 for the 2026 ICD-10-CM edition.

This reference covers ICD-10 Code M31.4 in full: its billable status, the clinical picture that justifies its use, synonyms accepted by the ICD-10-CM index, the code hierarchy, related vasculitis codes, documentation requirements, associated CPT codes, and the ICD-9-CM crosswalk.

ICD-10 Code M31.4: Code details and billable status

ICD-10 Code M31.4 is a billable and specific ICD-10-CM diagnosis code. No additional characters are required to make it valid for claim submission. The table below captures the core code facts that coders and billers need at a glance.

According to the CDC/NCHS ICD-10-CM web tool, M31.4 has been a valid, billable code since its adoption under ICD-10-CM and remains active in the 2026 edition. Coders working with claims management software can confirm this status directly within their billing workflow rather than relying on printed code books.

What is aortic arch syndrome (Takayasu arteritis)?

Takayasu arteritis is a rare, chronic, granulomatous large-vessel vasculitis. It targets the aorta and its primary branches, causing transmural inflammation that leads to stenosis, occlusion, or aneurysm formation over time.

The condition primarily affects women of childbearing age, with peak incidence between 15 and 40 years. It occurs worldwide but is more prevalent in East Asian and South Asian populations, according to peer-reviewed epidemiological literature.

From a coding standpoint, the name “aortic arch syndrome” reflects the anatomical territory most commonly involved: the aortic arch and its branches, including the subclavian, carotid, and renal arteries. The histopathological hallmark is granulomatous inflammation with giant cells, which places it alongside giant cell arteritis (M31.5) in the same parent category.

The key clinical distinction is age of onset: Takayasu affects patients under 40; giant cell arteritis typically presents over 50.

Synonyms and alternate names accepted under M31.4

The ICD-10-CM index accepts several terms that all map to ICD-10 Code M31.4. Using any of these in clinical documentation is acceptable, provided the diagnosis is confirmed and the documentation meets specificity requirements.

• Aortic arch syndrome [Takayasu] – the official ICD-10-CM descriptor
• Takayasu arteritis – the most common rheumatology and vascular surgery term
• Takayasu’s arteritis – possessive form, equally accepted
• Takayasu disease – alternate disease-name form
• Pulseless disease – historical name derived from the loss of radial pulse in advanced disease
• Aortoarteritis – a descriptor used in some international and South Asian literature

When the medical record uses any of these terms, the coder can confidently assign M31.4 without querying the provider. If the documentation says “probable Takayasu” or “suspected aortoarteritis,” do not code M31.4 yet. ICD-10-CM Official Guidelines require confirmed diagnoses for outpatient encounters.

For inpatient encounters, conditions described as “probable” may be coded as confirmed. Even then, a rheumatologist or vascular specialist’s attestation strengthens the record. Practices using structured clinical records can flag these nuances in the patient chart before the claim is submitted.

M31.4 in the ICD-10-CM code hierarchy

Understanding where ICD-10 Code M31.4 sits within the ICD-10-CM tabular list helps coders select the right code when multiple vasculitis codes are under consideration. The hierarchy flows from broad to specific.

The sibling codes within M31 are clinically distinct, and coders should not treat this category as interchangeable. The CMS ICD-10 codes page provides the official tabular list and annual update files for the full M31 group.

Key siblings relevant to vasculitis coding include M31.0 (hypersensitivity angiitis), M31.1 (thrombotic microangiopathy), M31.30/M31.31 (Wegener’s granulomatosis, coded to a 5th character), M31.5 (giant cell arteritis with polymyalgia rheumatica), and M31.6 (other giant cell arteritis).

Related ICD-10 codes for vasculitis and arteritis

Differentiating ICD-10 Code M31.4 from adjacent vasculitis codes is one of the most common coding challenges in rheumatology. The table below covers the codes most likely to appear on the same differential as Takayasu arteritis.

The AAPC’s ICD-10-CM code search provides full inclusion notes and exclusion markers for each of these codes. Coders researching the M31 group should check that tool alongside the official tabular list. For practices managing rheumatology billing, linking ICD-10 vasculitis codes correctly to procedure codes is a core function of a well-configured EHR integration.

Clinical documentation requirements for ICD-10 Code M31.4

A claim submitted with M31.4 will face scrutiny if the medical record does not support the diagnosis. Payers and auditors look for specific documentation elements. Missing any one of them is enough to trigger a request for additional information or a denial.

• Confirmed diagnosis statement: The record must include a clear statement that the diagnosing clinician confirms Takayasu arteritis. “Suspected” or “possible” language does not support M31.4 in outpatient coding.
• Specialist attestation: A rheumatologist or vascular surgeon’s confirmation strengthens the claim. Primary care documentation alone, without specialist referral notes, may not survive audit.
• Vessel involvement: Document which vessels are affected. Subclavian stenosis, carotid occlusion, or aortic wall thickening should be named explicitly rather than described as “vascular disease.”
• Disease activity status: Coders and auditors expect notes to reflect whether the patient is in an active inflammatory phase or remission. This context matters for associated CPT code selection (see below).
• Imaging or angiographic evidence: CT angiography, MRI angiography, or PET scan findings that demonstrate large-vessel inflammation or stenosis should be referenced in the clinical note, not just filed separately as a radiology report.

Practices using digital intake forms can build structured templates that prompt clinicians to capture these data points at the point of care, reducing the need for addenda requests later.

Specificity in the clinical note is what converts a billable code into a paid claim. Without it, coders default to the far less specific M31.9.

Symptoms and diagnostic criteria relevant to coding

Coders do not diagnose. But understanding the clinical picture helps verify that the documentation supports M31.4 before submission, and it informs the selection of associated procedure codes. The ACR classification criteria for Takayasu arteritis require at least three of six criteria to be met for classification. The criteria most frequently referenced in coding-relevant documentation include:

• Age of disease onset at or under 40 years
• Claudication of an extremity (limb fatigue or discomfort with activity)
• Decreased brachial artery pulse on at least one side
• Blood pressure difference greater than 10 mmHg between arms
• Bruit over a subclavian artery or the aorta on auscultation
• Arteriographic evidence of narrowing or occlusion of the aorta, its primary branches, or large arteries in the proximal upper or lower extremities

The sixth criterion, the angiographic finding, is the one most commonly recorded in imaging reports rather than the clinical note itself. Coders should confirm the treating physician has referenced this finding in their note, not just in a separate radiology report, to establish the link between the imaging and the confirmed diagnosis.

Practices managing complex rheumatology cases benefit from keeping imaging references and clinical impressions in one accessible patient record.

Associated CPT codes for M31.4 procedures

M31.4 as a diagnosis code pairs with a range of CPT procedure codes depending on the clinical encounter type. The table below covers the CPT codes most commonly associated with Takayasu arteritis management. Verify each against the current AMA CPT code set before submission, as code descriptors and coverage policies are subject to annual updates.

The CPT codes above are indicative based on typical Takayasu arteritis clinical pathways. Confirm medical necessity linkage to M31.4 for each code individually, and verify payer-specific LCD/NCD policies before submitting.

Practices often pair 99214 follow-up visits with 96413 infusion codes when biologic therapy is active. Integrated claims management software that flags common M31.4-CPT combinations catches mismatches before a claim leaves the practice.

Streamline your ICD-10 billing workflows

Pabau helps rheumatology and vascular practices attach accurate ICD-10 diagnosis codes to procedures, automate documentation prompts, and reduce claim errors. See how it works for your specialty.

Book a demo

ICD-9-CM to ICD-10 Code M31.4 crosswalk

Legacy system transitions, retrospective audits, and some payer reporting requirements still involve ICD-9-CM codes. The General Equivalence Mappings (GEMs) maintained by CMS and CDC/NCHS provide the official crosswalk. According to the ResDAC ICD coding resources, coders should always cite the official GEMs file when documenting crosswalk rationale for audit purposes, rather than relying on third-party conversion tools alone.

ICD-9-CM code 446.7 (Takayasu’s disease) maps forward to M31.4 as an approximate equivalent. The mapping is one-to-one, making this a relatively clean crosswalk compared to some conditions where ICD-9 codes fan out to multiple ICD-10 options.

Coders handling retroactive audits or payer reconciliation should confirm this against the current GEMs file. Practices pairing crosswalk tables with their EHR’s code search get faster retrospective lookups when the same reference feeds both systems.

Coding tips and common errors with ICD-10 Code M31.4

Three patterns account for most M31.4 errors seen in rheumatology and vascular coding audits. Each is preventable with the right review process.

• Confusing M31.4 with the giant cell arteritis codes M31.5 or M31.6: Both are large-vessel granulomatous vasculitides. The clinical separator is age of onset. If the record says the patient is 62 with jaw claudication and scalp tenderness, M31.5 or M31.6 is the correct code, not M31.4. Always confirm the patient’s age and the affected vessel territory before finalizing the code.
• Coding from the presenting symptom rather than the confirmed diagnosis: Presenting complaints like arm claudication, pulse asymmetry, or hypertension that is hard to control are symptoms, not diagnoses. Assign M31.4 only when the physician’s note confirms the Takayasu arteritis diagnosis. If the visit is for a symptom during the diagnostic workup, code the symptom.
• Omitting additional codes for complications or comorbidities: Active Takayasu arteritis frequently co-occurs with I10 hypertension, renal artery stenosis (I70.1), or aortic aneurysm (I71-range codes). These should be coded as additional diagnoses when documented, not absorbed into M31.4. Failing to code them leaves revenue on the table and understates clinical complexity for HCC risk adjustment purposes.

Practices building coding workflows in a practice management platform can set up code pairing alerts that prompt coders to check for these common co-occurring conditions when M31.4 is selected. The ICD10Data.com lookup tool is also useful for quickly verifying code inclusions and exclusions during chart review.

How Pabau supports ICD-10 coding workflows

Rare codes like ICD-10 Code M31.4 expose weaknesses in manual coding processes. When a rheumatologist sees one Takayasu case every few months, the documentation prompts are not embedded in anyone’s memory. They need to be embedded in the clinical workflow instead.

Pabau’s structured patient records let practices build specialty-specific note templates that prompt for the documentation elements M31.4 requires: confirmed diagnosis language, specialist attestation, vessel involvement, disease activity status, and imaging references. These prompts reduce addenda requests, cut the time between encounter and claim submission, and make the record audit-ready from the moment the clinician closes the note.

The platform’s claims management features allow practices to create code pairing rules, flag common M31.4-CPT combinations, and track denial patterns by code. For rheumatology and vascular practices handling complex, rare diagnoses, that kind of code-level intelligence is what separates a clean claim from a rework cycle.

More context on how HIPAA-compliant practice software supports documentation integrity is available in our compliance guide.

Practices wanting a broader view of specialty workflows can see how Pabau adapts across primary care and physical therapy practices alike.

Conclusion

ICD-10 Code M31.4 is straightforward to identify but easy to misassign. The most common errors, confusing it with M31.5, coding before diagnosis confirmation, and missing co-occurring conditions, are each addressable through better documentation prompts and code review workflows.

Pabau’s structured clinical records and claims management tools give rheumatology and vascular practices the workflow scaffolding they need to code rare diagnoses accurately from the first submission. See how leading EMR platforms handle rare code documentation, or speak with the team directly.

Continue your research

Need a structured approach to clinical note documentation? Safer clinical notes covers best practices for building defensible, audit-ready records across specialty settings.

Coding a different vascular diagnosis? ICD-10 code I81 covers portal vein thrombosis documentation and billing.

Managing a patient with chronic disease-related wasting? ICD-10 code R64 covers cachexia diagnosis and coding.

Billing a home visit for a chronic disease follow-up? CPT code 99350 covers established patient home visit billing.

Frequently asked questions